Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

InflaRx N.V. (IFRX)

4.55   -0.2 (-4.21%) 02-21 16:00
Open: 4.66 Pre. Close: 4.75
High: 4.6799 Low: 4.29
Volume: 440,741 Market Cap: 119M
InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.682 - 4.713 4.713 - 4.74
Low: 4.233 - 4.262 4.262 - 4.286
Close: 4.506 - 4.555 4.555 - 4.596

Technical analysis

as of: 2020-02-21 4:31:04 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.82     One year: 6.79
Support: Support1: 3.80    Support2: 3.07
Resistance: Resistance1: 4.98    Resistance2: 5.82
Pivot: 3.65
Moving Average: MA(5): 4.33     MA(20): 3.57
MA(100): 3.17     MA(250): 14.05
MACD: MACD(12,26): 0.22     Signal(9): 0.05
Stochastic oscillator: %K(14,3): 84.96     %D(3): 87.16
RSI: RSI(14): 69.15
52-week: High: 53.10  Low: 2.17  Change(%): -86.1
Average Vol(K): 3-Month: 62699  10-Days: 49686

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
IFRX has closed below upper band by 10.5%. Bollinger Bands are 141.5% wider than normal. The large width of the bands suggest high volatility as compared to IFRX's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Fri, 19 Jul 2019 19:48:14 +0000
Health Care Sector Update for 07/19/2019: MDGS,MTP,GLPG,IFRX

Wed, 05 Jun 2019 13:12:05 +0000
Health Care Sector Update for 06/05/2019: RWLK, IFRX, SRRA, JNJ, PFE, ABT, MRK, AMGN

Wed, 05 Jun 2019 17:43:19 +0000
Health Care Sector Update for 06/05/2019: CRON,CRON.TO,RWLK,IFRX

Wed, 05 Jun 2019 19:51:33 +0000
Health Care Sector Update for 06/05/2019: SRRA,CRON,CRON.TO,RWLK,IFRX

Fri, 19 Jul 2019 13:20:54 +0000
Health Care Sector Update for 07/19/2019: MTP, ATRA, IFRX, JNJ, ABT, MRK, PFE, AMGN

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 26.11
Shares Float (M) 16.19
% Held by Insiders 31.35
% Held by Institutions 20.24
Shares Short (K) 1040
Shares Short P. Month (K)

Stock Financials

EPS -1.387
Book Value (p.s.) 7.200
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -22.6
Return on Equity (ttm) -35.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E -3.28
P/E Growth Ratio -0.04
P/BV 0.63

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.